1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. MAGNETIC RESONANCE IMAGING SYSTEM MARKET BY ARCHITECTURE
5.1. Introduction
5.2. Closed MRI System
5.3. Open MRI System
6. MAGNETIC RESONANCE IMAGING SYSTEM MARKET BY FIELD STRENGTH
6.1. Introduction
6.2. Low-To-Mid Field (Up to 1.5T)
6.3. Mod-To-High Field (1.5 to 3T)
6.4. Ultra High Field (Above 3T)
7. MAGNETIC RESONANCE IMAGING SYSTEM MARKET BY APPLICATION
7.1. Introduction
7.2. Brain and Neurological Imaging
7.3. Spine and Musculoskeletal Imaging
7.4. Cardiac Imaging
7.5. Pelvic and Abdominal Imaging
7.6. Breast Imaging
7.7. Vascular Imaging
8. MAGNETIC RESONANCE IMAGING SYSTEM MARKET BY END-USER
8.1. Introduction
8.2. Hospitals
8.3. Diagnostics Centers
8.4. Others
9. MAGNETIC RESONANCE IMAGING SYSTEM MARKET BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. USA
9.2.2. Canada
9.2.3. Mexico
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Others
9.4. Europe
9.4.1. Germany
9.4.2. France
9.4.3. United Kingdom
9.4.4. Spain
9.4.5. Others
9.5. Middle East and Africa
9.5.1. Saudi Arabia
9.5.2. UAE
9.5.3. Others
9.6. Asia Pacific
9.6.1. China
9.6.2. Japan
9.6.3. India
9.6.4. South Korea
9.6.5. Thailand
9.6.6. Indonesia
9.6.7. Others
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
10.1. Major Players and Strategy Analysis
10.2. Market Share Analysis
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Competitive Dashboard
11. COMPANY PROFILES
11.1. Siemens Healthineers AG (Siemens)
11.2. GE HealthCare (General Electric Company)
11.3. Koninklijke Philips N.V.
11.4. Canon Medical Systems Corporation
11.5. Hitachi High-Tech Corporation
11.6. Fujifilm Holdings Corporation
11.7. Esaote SPA
11.8. Hologic, Inc.
11.9. Bruker Corporation
11.10. Hyperfine, Inc.
11.11. AURORA HEALTHCARE US CORP
12. APPENDIX
12.1. Currency
12.2. Assumptions
12.3. Base and Forecast Years Timeline
12.4. Key benefits for the stakeholders
12.5. Research Methodology
12.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES